Home » Topics » BioWorld Science

BioWorld Science
RSS

Mitochondrial DNA polymorphism linked to infant bronchopulmonary dysplasia

May 14, 2019

DSMB 36-month review of phase III RESOLVE-IT trial of elafibranor in NASH recommends continuation

May 14, 2019

NIH grant supports Ichor's development of antibodies against hantavirus infections

May 14, 2019

FDA approves Eylea to treat all stages of diabetic retinopathy

May 14, 2019

Oncolytic adenovirus with specificity for ARMS cells presented

May 14, 2019

Promising topline results announced from phase IIb study of seltorexant in major depressive disorder

May 14, 2019

ORIC Pharmaceuticals initiates phase Ib study of ORIC-101 in advanced solid tumors

May 14, 2019

Blueprint Medicines discloses activin receptor type-1 inhibitors

May 14, 2019

Exosomal PD-L1 identified as a cancer therapeutic target

May 14, 2019

Ajinomoto identifies new sweet receptor antagonists

May 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...